Mr. Peter Copetti reports

POET TECHNOLOGIES ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER ("COO")

Poet Technologies Inc. has appointed Dr. Subhash Deshmukh as chief operating officer of the company. Dr. Deshmukh will commence his new position on June 8, 2015, to give him time to fulfill his duties with his current employer.

Most recently, Dr. Deshmukh has been vice-president of emerging technologies and products at Applied Materials Inc. Prior to rejoining Applied Materials, he served as vice-president and general manager of the plasma products business unit as well as vice-president of business development for Varian Semiconductor Equipment Associates Inc. Varian Semiconductor was acquired by Applied Materials in November, 2011. Before moving to Varian Semiconductor, Dr. Deshmukh served as general manager of the dielectric etch products division of Applied Materials. He previously served in a number of executive and management positions with increasing responsibility at Applied Materials, Lam Research and AMI Semiconductors. Dr. Deshmukh holds a PhD in chemical sciences, has authored and co-authored over 55 technical articles, and has been granted over 27 patents, with several patents pending.

In making the announcement, Mr. Copetti, interim chief executive officer and executive co-chairman, commented: "We are very pleased to have Subhash join the company due to his proven track record in leading technology companies, both in technology development and strategies to create sustainable revenues. Subhash's appointment marks another crucial step in the company's succession plan as it moves toward monetizing the Poet process."

Dr. Deshmukh commented: "I see tremendous potential with Poet Technology's innovative approach to combining Si-based ICs with III-V materials-based optical components on the same chip that could revolutionize the mobility, telecommunications/networking, large data management and other technology sectors. I am very excited to be part of the team to drive this innovation into the market."

Stephane Gagnon, who has been serving as chief operating officer, has agreed to stay on and help the company through a period of transition in senior management. Mr. Copetti added: "I would like to thank Stephane for his hard work and tireless efforts during the time he served as chief operating officer of the company. Stephane was a key member in laying the foundation for the company's current direction."

Dr. Deshmukh was granted 1.5 million options to purchase common shares of the company. The options may be exercised at a price of $1.62 per share for a term of five years from the effective date of his employment, expiring on April 24, 2020. The option terms were determined based on current market price in accordance with the TSX Venture Exchange policies and company's stock option plan and the options will vest as follows: 250,000 options on the first anniversary of the effective date; 416,666 options on the second anniversary; and 416,667 options on each of the third and fourth anniversaries.

We seek Safe Harbor.